1.
Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers
by Einarsson, G G
Thorax, 2016, Vol.71 (9), p.795-803
2.
3.
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
by Sherrard, Laura J, PhD
The Lancet (British edition), 2014, Vol.384 (9944), p.703-713
4.
Antifungal photodynamic therapy
by Donnelly, Ryan F
Microbiological research, 2008, Vol.163 (1), p.1-12
5.
S117 The effect of cigarette and electronic cigarette vapour on bacteria in chronic lung infection
by Gilpin, DF
Thorax, 2017, Vol.72 (Suppl 3), p.A71
6.
S104 The culture microbiome in the lungs of patients with COPD
by Einarsson, G G
Thorax, 2011, Vol.66 (Suppl 4), p.A48-A49
7.
Predictors of adherence to treatment in bronchiectasis
by McCullough, Amanda R
Respiratory medicine, 2015, Vol.109 (7), p.838-845
8.
Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms
by FIELD, T. R
European journal of clinical microbiology & infectious diseases, 2005, Vol.24 (10), p.677-687
9.
S22 The Effect Of Cigarette Smoke On Important Pathogens In Copd Lung Infection
by McGown, K
Thorax, 2014, Vol.69 (Suppl 2), p.A14-A14
10.
S20 Impact of azithromycin on the post-lung transplant microbiota
by Spence, C
Thorax, 2017, Vol.72 (Suppl 3), p.A15
11.
S21 Culture Independent Identification Of Bacterial Communities In The Respiratory Tract Of Patients With Copd, Healthy Non-smokers And Healthy Smokers
by Einarsson, G.
Thorax, 2014, Vol.69 (Suppl 2), p.A13-A14
12.
P95 Exploring the timing of Hypertonic Saline (HTS) and Airways Clearance Techniques (ACT) in Cystic Fibrosis (CF): a cross over study
by O’Neill, K
Thorax, 2016, Vol.71 (Suppl 3), p.A134-A135
13.
S44 Lung clearance index (LCI) and FEV1 correlate equally with treatment burden as measured by cystic fibrosis questionnaire-revised (CFQ-R)
by O'Neill, K
Thorax, 2011, Vol.66 (Suppl 4), p.A23-A23
14.
15.
S103 Microbial community composition in the lungs of patients with Cystic Fibrosis and non-CF bronchiectasis
by Einarsson, G. G.
Thorax, 2011, Vol.66 (Suppl 4), p.A48-A48
16.
P103 Culture and culture independant identification of bacterial communities in the cystic fibrosis respiratory tract
by Einarsson, GG
Thorax, 2013, Vol.68 (Suppl 3), p.A121-A121
17.
S10 Lung Clearance Index (LCI) and Pseudomonous aeruginosa in adults and children with Cystic Fibrosis (CF)
by O'Neill, K
Thorax, 2013, Vol.68 (Suppl 3), p.A8-A9
18.
P181 Adherence to Treatment in Patients with Bronchiectasis Infected with Pseudomonas Aeruginosa
by McCullough, A R
Thorax, 2012, Vol.67 (Suppl 2), p.A142-A142
19.
CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With Ivacaftor
by Ronan, Nicola J
Chest, 2018, Vol.153 (2), p.395-403
